ADAM17 and severe acute respiratory syndrome: Taking into consideration that cellular factors such as the Tumor Necrosis Factor-alpha (TNF-α) converting enzyme (TACE) facilitate SARS-CoV entry (Haga et al., 2008), it is reasonable to suggest that TACE inhibitors could hinder SARS-CoV infection.